Clinical Considerations in Renal Cell Carcinoma: Current Evidence, Guideline Recommendations, and a View to the Future

Download these slides from a live webinar for the most recent data on the use of adjuvant therapy for nonmetastatic RCC and the optimal first line treatment options for patients with advanced RCC.

Naomi B. Haas, MD Released: June 5, 2022

Download these slides from a live webinar for the most recent data on the selection and sequencing of therapy for patients with advanced RCC after progression on first-line therapy.

Katy Beckermann, MD, PhD Released: June 5, 2022

Download these slides from a live webinar for the most recent data on the optimal management of treatment-related adverse events for patients with RCC.

Eric Jonasch, MD Released: June 5, 2022

Drs Katy Beckermann, Naomi Haas, and Eric Jonasch provide key updates on the use of available regimens in renal cell carcinoma across the adjuvant, first-line, and second-line settings.

Katy Beckermann, MD, PhD Naomi B. Haas, MD Eric Jonasch, MD Released: August 1, 2022